A5092392649- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Pregnancy and preeclampsia studies
- Maternal and fetal healthcare
- Cardiac pacing and defibrillation studies
- Gestational Trophoblastic Disease Studies
- Potassium and Related Disorders
- Parathyroid Disorders and Treatments
- Cardiac Valve Diseases and Treatments
State Hospital
2024
Gaziantep University
2024
Glycogen synthase kinase 3β (GSK3β) is an enzyme that has roles in the pathogenesis of heart failure (HF). We try to reveal serum GSK3β levels types HF.
Abstract Background Glycogen synthase kinase 3β (GSK3β) is an enzyme that has roles in the pathogenesis of heart failure (HF). We try to reveal serum GSK3β levels types HF. Objectives In this study, we evaluated HF patients. Also, tried elucidate any possible relationship between and disease severity among three different Methods performed a prospective study enrolled 112 patients: 50 patients with preserved ejection fraction (HFpEF) group, 30 mildly reduced (HFmrEF) 32 group (HFrEF). also...
In this study, we measured the levels of Kelch-like ECH-associated protein 1 (KEAP1), which has potential antioxidant capacity, among non-ST elevation myocardial infarction (NSTEMI) patients compared with healthy controls. We also investigated possible association between KEAP1 and GRACE score, is a universal risk score commonly used for acute infarction.As patient group, 78 admitted to our center diagnosis NSTEMI were included in study. As control 77 individuals found have normal coronary...